Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2015, Article ID 729191, 5 pages
http://dx.doi.org/10.1155/2015/729191
Research Article

Urinary F2-Isoprostanes and Metabolic Markers of Fat Oxidation

1School of Public Health, Georgia State University, 140 Decatur Street, Urban Life Building, Atlanta, GA 30303, USA
2Wake Forest School of Medicine, Public Health Sciences, Winston-Salem, NC 27157, USA
3Duke Cancer Institute, Duke University Medical Center, 2424 Erwin Road, Durham, NC 27705, USA
4Lipomics Technologies, Division of Metabolon, 3410 Industrial Boulevard, West Sacramento, CA 95691, USA
5Center for Genomics and Personalized Medicine Research, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA

Received 18 December 2014; Revised 19 January 2015; Accepted 25 January 2015

Academic Editor: Janusz Gebicki

Copyright © 2015 Dora Il’yasova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Basu, “F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications,” Antioxidants and Redox Signaling, vol. 10, no. 8, pp. 1405–1434, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Il'yasova, P. Scarbrough, and I. Spasojevic, “Urinary biomarkers of oxidative status,” Clinica Chimica Acta, vol. 413, no. 19-20, pp. 1446–1453, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Il'Yasova, I. Spasojevic, F. Wang et al., “Urinary biomarkers of oxidative status in a clinical model of oxidative assault,” Cancer Epidemiology Biomarkers and Prevention, vol. 19, no. 6, pp. 1506–1510, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Otani, “Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome,” Antioxidants and Redox Signaling, vol. 15, no. 7, pp. 1911–1926, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Il'Yasova, F. Wang, I. Spasojevic, K. Base, R. B. D'Agostino Jr., and L. E. Wagenknecht, “Urinary F 2-isoprostanes, obesity, and weight gain in the IRAS cohort,” Obesity, vol. 20, no. 9, pp. 1915–1921, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Il'yasova, I. Spasojevic, K. Base et al., “Urinary f2-isoprostanes as a biomarker of reduced risk of type 2 diabetes,” Diabetes Care, vol. 35, no. 1, pp. 173–174, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. A. M. Kanaya, C. L. Wassel, P. J. Stoddard et al., “F2-isoprostanes and adiposity in older adults,” Obesity, vol. 19, no. 4, pp. 861–867, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Il'yasova, J. D. Morrow, and L. E. Wagenknecht, “Urinary F 2-isoprostanes are not associated with increased risk of type 2 diabetes,” Obesity Research, vol. 13, no. 9, pp. 1638–1644, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. T. R. Figueira, M. H. Barros, A. A. Camargo et al., “Mitochondria as a source of reactive oxygen and nitrogen species: from molecular mechanisms to human health,” Antioxidants and Redox Signaling, vol. 18, no. 16, pp. 2029–2074, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. C. L. Quinlan, I. V. Perevoshchikova, M. Hey-Mogensen, A. L. Orr, and M. D. Brand, “Sites of reactive oxygen species generation by mitochondria oxidizing different substrates,” Redox Biology, vol. 1, no. 1, pp. 304–312, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. R. A. Jackson, J. B. Hamling, P. M. Blix, and J. D. N. Nabarro, “Relationship among peripheral glucose uptake, oxygen consumption, and glucose turnover in postabsorptive man,” The Journal of Clinical Endocrinology & Metabolism, vol. 59, no. 5, pp. 857–860, 1984. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Heilbronn, S. R. Smith, and E. Ravussin, “Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus,” International Journal of Obesity, vol. 28, supplement 4, pp. S12–S21, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Margonis, I. G. Fatouros, A. Z. Jamurtas et al., “Oxidative stress biomarkers responses to physical overtraining: implications for diagnosis,” Free Radical Biology and Medicine, vol. 43, no. 6, pp. 901–910, 2007. View at Google Scholar
  14. L. W. Jones, N. D. Eves, I. Spasojevic, F. Wang, and D. Il'yasova, “Effects of aerobic training on oxidative status in postsurgical non-small cell lung cancer patients: a pilot study,” Lung Cancer, vol. 72, no. 1, pp. 46–51, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Weyer, S. Snitker, C. Bogardus, and E. Ravussin, “Energy metabolism in African Americans: potential risk factors for obesity,” The American Journal of Clinical Nutrition, vol. 70, no. 1, pp. 13–20, 1999. View at Google Scholar · View at Scopus
  16. D. Il'Yasova, F. Wang, I. Spasojevic, K. Base, R. B. D'Agostino Jr., and L. E. Wagenknecht, “Racial differences in urinary F2-isoprostane levels and the cross-sectional association with BMI,” Obesity (Silver Spring), vol. 20, no. 10, pp. 2147–2150, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Il'yasova, F. Wang, R. B. D'Agostino Jr., A. Hanley, and L. E. Wagenknecht, “Prospective association between fasting NEFA and type 2 diabetes: impact of post-load glucose,” Diabetologia, vol. 53, no. 5, pp. 866–874, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Krug, G. Kastenmüller, F. Stückler et al., “The dynamic range of the human metabolome revealed by challenges,” The FASEB Journal, vol. 26, no. 6, pp. 2607–2619, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Lehmann, X. Zhao, C. Weigert et al., “Medium chain acylcarnitines dominate the metabolite pattern in humans under moderate intensity exercise and support lipid oxidation,” PLoS ONE, vol. 5, no. 7, Article ID e11519, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. S. H. Adams, “Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state,” Advances in Nutrition, vol. 2, no. 6, pp. 445–456, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. F. B. Stephens, D. Constantin-teodosiu, and P. L. Greenhaff, “New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle,” The Journal of Physiology, vol. 581, no. 2, pp. 431–444, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. C. L. Hoppel and S. M. Genuth, “Urinary excretion of acetylcarnitine during human diabetic and fasting ketosis.,” The American Journal of Physiology, vol. 243, no. 2, pp. E168–E172, 1982. View at Google Scholar · View at Scopus